Clinical Trials Sponsored by National Development and Research Institutes, Inc

Total 5691 results

National Development and Research Institutes, Inc.

Unknown

Mobile Intervention for Young Opioid Users

Opioid-Related Disorders

United States
National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
National Development and Research Institutes, Inc.

Unknown

The Staying Safe Intervention (Ssafe)

Hepatitis C | Opioid Use

United States
National Development and Research Institutes, Inc.

Unknown

Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology

HIV Testing

United States
Rowan University
National Development and Research Institutes, Inc.

Completed

Incentives for Internet-based Adherence to SMBG for Teens With T1D

Contingent Versus Noncontingent Incentives
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Mobile Psychosocial Interventions for MMT Clients (MobileMMT)

Substance Abuse | Opioid Abuse

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Transmission Reduction Intervention Project (TRIP)

HIV

United States, Greece, Ukraine
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention

HIV Infections | Hepatitis | Sexually Transmitted Infections

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Colorado Women's TC Project

Substance-Related Disorders

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Re-Entry MTC for Offenders With MICA Disorders

Substance-Related Disorders | Mental Disorders

United States
National Institute on Drug Abuse (NIDA)
National Development and Research Institutes, Inc.

Completed

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Substance-Related Disorders | Mental Disorders | Dual Diagnosis

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Technological Innovations in Behavioral Treatments for Cigarette Smoking

Cigarette Smoking

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Internet-based Group Contingency Management to Promote Smoking Abstinence

Cigarette Smoking

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

HIV Prevention Intervention for Couples

Acquired Immunodeficiency Syndrome

United States
Kansas State University
National Development and Research Institutes, Inc.

Completed

Army Training at High Intensity Study (ATHIS)

Obesity

United States
University Hospital, Montpellier
National Development and Research Institutes, Inc.

Active, not recruiting

Measure of the Potential Evoked by Electric Stimulation (PE&CE)

Low Grade Glioma of Brain

France
Kansas State University
National Development and Research Institutes, Inc.

Completed

The First 20 Fire Academy Recruits Exercise Training Program

Physical Fitness

United States
Syracuse VA Medical Center
National Development and Research Institutes, Inc.

Completed

Peer Supported Web-based CBT for OEF/OIF Veterans With PTSD and Substance Misuse

Substance Use Disorders | Stress Disorders, Post-traumatic

United States
Embry-Riddle Aeronautical University
National Development and Research Institutes, Inc.

Recruiting

EaseAlert: Tactile Firefighter Alerting System

Sleep | Heart Rate | Sleep Habit

United States
National Development and Research Institutes, Inc.
Treatment Alternatives for Safe Communities

Unknown

Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts

Improving Treatment for Opioid Use Disorder in Courts

United States
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Computer-delivered Psychosocial Intervention for Adolescent Substance Use Disorders

Substance-Related Disorders | Alcohol-Related Disorders | Marijuana Abuse

United States
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Science-Based Treatment for Opioid-Dependent Adolescents

Opioid-Dependence Among Adolescents

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA); Beth Israel Medical Center

Completed

Web-based Cognitive-behavior Therapy (CBT) for Opioid-treated, Chronic Pain Patients With Aberrant Behavior (WebCBTPain)

Chronic Pain

United States
University of Chicago
University of Athens; National Development and Research Institutes, Inc.

Completed

Public Health Targeting of PrEP at HIV Positives' Bridging Networks (SOPHOCLES)

HIV

Greece
Cipherome, Inc.
DHR Health Institute for Research and Development

Completed

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics (CARES2)

Myocardial Infarction | Ischemic Stroke | Thrombosis | Bleeding | Stent Thrombosis

United States
VA Office of Research and Development
Regenstrief Institute, Inc.

Completed

Evaluation of VLER-Indiana Health Information Exchange Demonstration Project (VLER-IHIE)

Cardiovascular Diseases | Heart Failure | Diabetes Mellitus | Asthma | Osteoporosis

United States
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
Criterium, Inc.
EMD Serono Research & Development Institute, Inc.

Terminated

CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC

Advanced Non-Small Cell Lung Cancer With MET Mutations

United States
Primex Clinical Laboratories, Inc.
Research & Development Institute, Inc.

Unknown

Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics

Patients on Medications Metabolized Via CYP450

United States
ChemRar Research and Development Institute, LLC

Not yet recruiting

A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Anxiety Disorder Generalized
Ina-Respond
Center for Research and Development of Health Resources and Services, National...

Recruiting

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia (FVR)

Covid19 | Infectious Disease | SARS-CoV Infection

Indonesia
ChemRar Research and Development Institute, LLC

Completed

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Anxiety Disorder Generalized

Russian Federation
National Development and Research Institutes, Inc.
The University of Texas Health Science Center, Houston

Completed

The First Twenty (TF20) for Volunteer Firefighters in a Clinic Based Setting

Obesity

United States
Baylor College of Medicine
Temple University; National Development and Research Institutes, Inc.; MRC Human... and other collaborators

Completed

Impact of an Online Behavioral Weight Loss Program

Obesity | Overweight

United States, United Kingdom
The University of Texas Health Science Center,...
National Development and Research Institutes, Inc.

Completed

The First Twenty for Volunteer Firefighters

Cardiovascular Diseases | Obesity | Occupational Injuries

United States
VA Office of Research and Development
Oncovir, Inc.

Not yet recruiting

Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC (HAITEN-ICI)

Stage IV NSCLC

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Recruiting

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Acute Infectious Keratoconjunctivitis

United States, Thailand
Visterra, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Influenza

United States, Estonia, South Africa, Bulgaria, Serbia, Ukraine, Latvia
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Zika Virus

United States, Puerto Rico
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

Zika Virus

United States
Achaogen, Inc.
Defense Medical Research and Development Program

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

Healthy Volunteer

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA); University of Puerto Rico; Hanoi Medical...

Completed

Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities

Hepatitis C | HIV | Chlamydia | Gonorrhea | Syphilis

Vietnam
VA Office of Research and Development
Analydata, Inc

Recruiting

Stellate Ganglion Block for PTSD (SGB-PTSD)

Post-traumatic Stress Disorder

United States
VA Office of Research and Development
Analydata, Inc

Completed

Acupuncture for PTSD (PTSD ACU)

Posttraumatic Stress Disorder

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

Dry Eye Disease

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

Sublingual vs IV Atropine Bioavailability Study

Toxic Effect of Organophosphate and Carbamate Insecticides

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

SARS-CoV-2

United States
Genentech, Inc.
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia (COVASTIL)

COVID-19 Pneumonia

United States, Spain, Brazil, Mexico
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

BARDA Securing Anthrax Immunity For the Elderly (B-SAFE)

Anthrax

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Influenza, Human

United States

Clinical Trials Sponsored by National Development and Research Institutes, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations